Analysis of short-term reproducibility of arterial vasoreactivity by pulse-wave analysis after pharmacological challenge

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 1, 2009, Pages 49-54

  Paul, Biju ^a   Hewitson, Christopher L ^a   Woodman, Richard J ^a   Mangoni, Arduino A ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Augmentation index; Endothelium; Pulse wave analysis; Repeatability; Reproducibility; Vasodilatation

Indexed keywords

GLYCERYL TRINITRATE; SALBUTAMOL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; MALE; PULSE WAVE; REPRODUCIBILITY; VASCULAR ENDOTHELIUM; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; ENDOTHELIUM, VASCULAR; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; RADIAL ARTERY; REPRODUCIBILITY OF RESULTS; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 58549120801     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05033.x     Document Type: Article

References (44)

1. O'Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. Br. J. Clin. Pharmacol. 2001 51 : 507 22.
2. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001 38 : 434 8.
3. Weber T, Auer J, O'Rourke MF et al. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur. Heart J. 2005 26 : 2657 63.
4. Chirinos JA, Zambrano JP, Chakko S et al. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005 45 : 980 5.
5. Mullan BA, Ennis CN, Fee HJ, Young IS, McCance DR. Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia. Am. J. Physiol. Heart Circ. Physiol. 2004 287 : H1262 8.
6. Nurnberger J, Keflioglu-Scheiber A, Opazo Saez AM, Wenzel RR, Philipp T, Schafers RF. Augmentation index is associated with cardiovascular risk. J. Hypertens. 2002 20 : 2407 14.
7. Smith JC, Evans LM, Wilkinson I et al. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: A randomized, double-blind, placebo-controlled study. Clin. Endocrinol. 2002 56 : 493 501.
8. Williams B, Lacy PS, Thom SM et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006 113 : 1213 25.
9. Hayward CS, Kraidly M, Webb CM, Collins P. Assessment of endothelial function using peripheral waveform analysis: A clinical application. J. Am. Coll. Cardiol. 2002 40 : 521 8.
10. Wilkinson IB, Hall IR, MacCallum H et al. Pulse-wave analysis: Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler. Thromb. Vasc. Biol. 2002 22 : 147 52.
11. Filipovsky J, Svobodova V, Pecen L. Reproducibility of radial pulse wave analysis in healthy subjects. J. Hypertens. 2000 18 : 1033 40.
12. Papaioannou TG, Stamatelopoulos KS, Gialafos E et al. Monitoring of arterial stiffness indices by applanation tonometry and pulse wave analysis: Reproducibility at low blood pressures. J. Clin. Monit. Comput. 2004 18 : 137 44.
13. Papaioannou TG, Karatzis EN, Karatzi KN et al. Hour-to-hour and week-to-week variability and reproducibility of wave reflection indices derived by aortic pulse wave analysis: Implications for studies with repeated measurements. J. Hypertens. 2007 25 : 1678 86.
14. Savage MT, Ferro CJ, Pinder SJ, Tomson CR. Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin. Sci. 2002 103 : 59 65.
15. Siebenhofer A, Kemp C, Sutton A, Williams B. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J. Hum. Hypertens. 1999 13 : 625 9.
16. Wilkinson IB, Fuchs SA, Jansen IM et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J. Hypertens. 1998 16 : 2079 84.
17. Frimodt-Moller M, Nielsen AH, Kamper AL, Strandgaard S. Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease. Nephrol. Dial. Transplant. 2008 23 : 594 600.
18. Liang YL, Teede H, Kotsopoulos D et al. Non-invasive measurements of arterial structure and function: Repeatability, interrelationships and trial sample size. Clin. Sci. 1998 95 : 669 79.
19. Wilkinson IB, Webb DJ. Venous occlusion plethysmography in cardiovascular research: Methodology and clinical applications. Br. J. Clin. Pharmacol. 2001 52 : 631 46.
20. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur. Heart J. 1993 14 : 160 7.
21. Gatzka CD, Cameron JD, Dart AM et al. Correction of carotid augmentation index for heart rate in elderly essential hypertensives. ANBP2 Investigators. Australian comparative outcome trial of angiotensin-converting enzyme inhibitor- and diuretic-based treatment of hypertension in the elderly. Am. J. Hypertens. 2001 14 : 573 7.
22. Giraudeau B, Mary JY. Planning a reproducibility study: How many subjects and how many replicates per subject for an expected width of the 95 per cent confidence interval of the intraclass correlation coefficient. Stat. Med. 2001 20 : 3205 14.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 i : 307 10.
24. Shaw JA, Chin-Dusting JP, Kingwell BA, Dart AM. Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation 2001 103 : 806 12.
25. Tomlinson HS, Corlett SA, Chrystyn H. Dose-response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after an inhalation. Br. J. Clin. Pharmacol. 2003 56 : 225 7.
26. Noonan PK, Benet LZ. Incomplete and delayed bioavailability of sublingual nitroglycerin. Am. J. Cardiol. 1985 55 : 184 7.
27. de Roos NM, Bots ML, Schouten EG, Katan MB. Within-subject variability of flow-mediated vasodilation of the brachial artery in healthy men and women: Implications for experimental studies. Ultrasound Med. Biol. 2003 29 : 401 6.
28. de Roos NM, Siebelink E, Bots ML, van Tol A, Schouten EG, Katan MB. Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation. Eur. J. Clin. Nutr. 2002 56 : 674 9.
29. de Roos NM, Bots ML, Siebelink E, Schouten E, Katan MB. Flow-mediated vasodilation is not impaired when HDL-cholesterol is lowered by substituting carbohydrates for monounsaturated fat. Br. J. Nutr. 2001 86 : 181 8.
30. de Roos NM, Bots ML, Katan MB. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler. Thromb. Vasc. Biol. 2001 21 : 1233 7.
31. Herrington DM, Fan L, Drum M et al. Brachial flow-mediated vasodilator responses in population-based research: Methods, reproducibility and effects of age, gender and baseline diameter. J. Cardiovasc. Risk 2001 8 : 319 28.
32. Sorensen KE, Celermajer DS, Spiegelhalter DJ et al. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br. Heart J. 1995 74 : 247 53.
33. Hale G, Paul-Labrador M, Dwyer JH, Merz CN. Isoflavone supplementation and endothelial function in menopausal women. Clin. Endocrinol. 2002 56 : 693 701.
34. Berry KL, Skyrme-Jones RA, Meredith IT. Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation. Clin. Sci. 2000 99 : 261 7.
35. Hashimoto M, Akishita M, Eto M et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995 92 : 3431 5.
36. Lind L, Hall J, Johansson K. Evaluation of four different methods to measure endothelium-dependent vasodilation in the human peripheral circulation. Clin. Sci. 2002 102 : 561 7.
37. Uehata A, Lieberman EH, Gerhard MD et al. Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery. Vasc. Med. 1997 2 : 87 92.
38. Welsch MA, Allen JD, Geaghan JP. Stability and reproducibility of brachial artery flow-mediated dilation. Med. Sci. Sports Exerc. 2002 34 : 960 5.
39. Hijmering ML, Stroes ES, Pasterkamp G, Sierevogel M, Banga JD, Rabelink TJ. Variability of flow mediated dilation: Consequences for clinical application. Atherosclerosis 2001 157 : 369 73.
40. Malik J, Wichterle D, Haas T, Melenovsky V, Simek J, Stulc T. Repeatability of noninvasive surrogates of endothelial function. Am. J. Cardiol. 2004 94 : 693 6.
41. Harris RA, Padilla J, Rink LD, Wallace JP. Variability of flow-mediated dilation measurements with repetitive reactive hyperemia. Vasc. Med. 2006 11 : 1 6.
42. Peretz A, Leotta DF, Sullivan JH et al. Flow mediated dilation of the brachial artery: An investigation of methods requiring further standardization. BMC Cardiovasc. Disord. 2007 7 : 11.
43. Thijssen DH, Bleeker MW, Smits P, Hopman MT. Reproducibility of blood flow and post-occlusive reactive hyperaemia as measured by venous occlusion plethysmography. Clin. Sci. 2005 108 : 151 7.
44. Vanmolkot FH, de Hoon JN. Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography. Br. J. Clin. Pharmacol. 2005 59 : 387 97.